Showing results (241-250 of 661) with videos related to
Sort By:
Pageof 67
Nature Cancer|May 31, 2022
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumorsHongru Zhang, Pengfei Yu, Vivek S Tomar, et al.Nature Cancer|May 9, 2022
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemiaBrandon J Aubrey, Jevon A Cutler, Wallace Bourgeois, et al.Nature Cancer|June 6, 2022
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin H Lin, Justine C Rutter, Abigail Xie, et al.Nature Cancer|June 10, 2022
Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitorsAli Vaziri-Gohar, Joel Cassel, Farheen S Mohammed, et al.Nature Cancer|June 28, 2022
Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancerKevin M Boehm, Emily A Aherne, Lora Ellenson, et al.Nature Cancer|March 3, 2020
A practical framework and online tool for mutational signature analyses show inter-tissue variation and driver dependenciesAndrea Degasperi, Tauanne Dias Amarante, Jan Czarnecki, et al.Nature Cancer|June 14, 2021
Activation of p38α stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungsJun Gui, Farima Zahedi, Angelica Ortiz, et al.Nature Cancer|April 17, 2023
Impact of context-dependent autophagy states on tumor progressionMohamad Assi, Alec C KimmelmanNature Cancer|May 4, 2023
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillanceLoretah Chibaya, Katherine C Murphy, Kelly D DeMarco, et al.Nature Cancer|April 2, 2021
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemiaKoichi Oshima, Junfei Zhao, Pablo Pérez-Durán, et al.Pageof 67